<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Viruses</journal-id><journal-id journal-id-type="iso-abbrev">Viruses</journal-id><journal-id journal-id-type="publisher-id">viruses</journal-id><journal-title-group><journal-title>Viruses</journal-title></journal-title-group><issn pub-type="epub">1999-4915</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11680359</article-id><article-id pub-id-type="doi">10.3390/v16121828</article-id><article-id pub-id-type="publisher-id">viruses-16-01828</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>New Insights on Hepatitis B Virus Viral Transcription in Single Hepatocytes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Peng</surname><given-names>Bo</given-names></name><xref rid="af1-viruses-16-01828" ref-type="aff">1</xref><xref rid="c1-viruses-16-01828" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Lixia</given-names></name><xref rid="af1-viruses-16-01828" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1305-7404</contrib-id><name><surname>Li</surname><given-names>Wenhui</given-names></name><xref rid="af1-viruses-16-01828" ref-type="aff">1</xref><xref rid="af2-viruses-16-01828" ref-type="aff">2</xref><xref rid="c1-viruses-16-01828" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Beran</surname><given-names>Rudolf K.</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Fletcher</surname><given-names>Simon P.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-viruses-16-01828"><label>1</label>National Institute of Biological Sciences, Beijing 102206, China; <email>panlixia@nibs.ac.cn</email></aff><aff id="af2-viruses-16-01828"><label>2</label>Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 100084, China</aff><author-notes><corresp id="c1-viruses-16-01828"><label>*</label>Correspondence: <email>pengbo@nibs.ac.cn</email> (B.P.); <email>liwenhui@nibs.ac.cn</email> (W.L.)</corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><volume>16</volume><issue>12</issue><elocation-id>1828</elocation-id><history><date date-type="received"><day>24</day><month>9</month><year>2024</year></date><date date-type="rev-recd"><day>21</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>22</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The hepatitis B virus (HBV) infects approximately 290 million people globally, with chronic infection sustained by persistent viral gene expression. Recent single-cell analyses of HBV viral transcripts have uncovered novel features of HBV transcription and provided fresh insights into its regulation at the single-cell level. In this review, we summarize the latest advancements in understanding HBV viral transcription in individual hepatocytes and highlight emerging technologies that hold promise for future research.</p></abstract><kwd-group><kwd>HBV</kwd><kwd>transcription</kwd><kwd>single cell</kwd></kwd-group><funding-group><award-group><funding-source>Beijing Scholar program</funding-source></award-group><funding-statement>This work was supported by the Beijing Scholar program.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-viruses-16-01828"><title>1. Introduction</title><p>The hepatitis B virus (HBV) is a 3.2 kb DNA virus, but its replication occurs through reverse transcription, which can be effectively inhibited by current nucleos(t)ide analogue (NUC) drugs. However, these drugs do not inhibit viral gene expression and, therefore, have no direct impact on viral antigenemia, an indicator of active infection [<xref rid="B1-viruses-16-01828" ref-type="bibr">1</xref>,<xref rid="B2-viruses-16-01828" ref-type="bibr">2</xref>,<xref rid="B3-viruses-16-01828" ref-type="bibr">3</xref>]. A productive HBV infection relies on the active transcription of covalently closed circular (ccc) DNA, an episomal viral minichromosome located in the nucleus. This cccDNA, driven by four promoters and two enhancers, serves as the template for all viral transcripts. These include the 3.5 kb pregenomic (pg) RNA, which acts as a replication intermediate and codes for both the core protein and polymerase; the 3.5 kb precore (preC) RNA for HBV e antigen (HBeAg); the 2.4 kb preS1 RNA for the large envelope protein (L); the 2.1 kb preS2/S RNA for the medium (M) and small (S) envelope proteins; and the 0.7 kb RNA for HBV X protein (HBx) [<xref rid="B4-viruses-16-01828" ref-type="bibr">4</xref>,<xref rid="B5-viruses-16-01828" ref-type="bibr">5</xref>,<xref rid="B6-viruses-16-01828" ref-type="bibr">6</xref>]. The presence of HBV surface antigen (HBsAg), especially alongside HBeAg in the blood, signifies active HBV infection [<xref rid="B7-viruses-16-01828" ref-type="bibr">7</xref>].</p><p>The nonstructural HBx protein plays a crucial role in productive cccDNA transcription [<xref rid="B8-viruses-16-01828" ref-type="bibr">8</xref>,<xref rid="B9-viruses-16-01828" ref-type="bibr">9</xref>]. However, its exact mechanism of action remains under investigation. The best-known mechanism involves the induction of the degradation of the structural maintenance of the chromosome 5/6 (Smc5/6) complex, which releases transcriptional suppression mediated by the complex [<xref rid="B10-viruses-16-01828" ref-type="bibr">10</xref>,<xref rid="B11-viruses-16-01828" ref-type="bibr">11</xref>]. Inactivated cccDNA is not randomly distributed within the nucleus but appears to localize in specific regions [<xref rid="B12-viruses-16-01828" ref-type="bibr">12</xref>,<xref rid="B13-viruses-16-01828" ref-type="bibr">13</xref>].</p><p>An HBV-infected cell may contain several cccDNA molecules, which are highly compacted, with approximately two-thirds of the genome coding for at least two genes. All viral transcripts from a single cccDNA molecule share the same 3&#x02032; end [<xref rid="B5-viruses-16-01828" ref-type="bibr">5</xref>]. These characteristics present technical challenges for distinguishing between viral transcripts using conventional analytical approaches. In recent years, the transcription start sites (TSSs) of HBV genes have been elucidated in greater detail using techniques such as full-length 5&#x02032;RACE (rapid amplification of cDNA ends) and CAGE (cap analysis of gene expression) [<xref rid="B14-viruses-16-01828" ref-type="bibr">14</xref>,<xref rid="B15-viruses-16-01828" ref-type="bibr">15</xref>]. However, since these studies were based on bulk cell samples, they could not distinguish viral transcripts originating from different hepatocytes or determine the levels of viral transcripts from different cccDNA molecules within a single cell.</p><p>Given that the liver contains hepatocytes with distinct functions and that there may be phenotype mixing (i.e., trans-complementation of variants) of viral infections within cells, it is crucial to understand viral transcription at the single-cell level. This understanding is key to developing antiviral strategies aimed at permanently silencing viral transcription. Recent advancements in single-cell sequencing and single-molecule imaging now allow transcriptome studies in thousands of individual cells simultaneously [<xref rid="B16-viruses-16-01828" ref-type="bibr">16</xref>,<xref rid="B17-viruses-16-01828" ref-type="bibr">17</xref>,<xref rid="B18-viruses-16-01828" ref-type="bibr">18</xref>]. The emerging research, some of it on natural infections with or without drug treatments, using recently developed techniques such as droplet digital PCR (ddPCR), single-cell sequencing, and in situ hybridization, has uncovered important characteristics of HBV transcription at the single-cell level [<xref rid="B19-viruses-16-01828" ref-type="bibr">19</xref>,<xref rid="B20-viruses-16-01828" ref-type="bibr">20</xref>,<xref rid="B21-viruses-16-01828" ref-type="bibr">21</xref>,<xref rid="B22-viruses-16-01828" ref-type="bibr">22</xref>,<xref rid="B23-viruses-16-01828" ref-type="bibr">23</xref>]. In this review, we summarize the recent progress and discuss the significance of these observations for HBV transcription in individual cells (<xref rid="viruses-16-01828-f001" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec2-viruses-16-01828"><title>2. Viral Gene Expression Profiling</title><sec id="sec2dot1-viruses-16-01828"><title>2.1. Transcription Initiation of HBV cccDNA</title><p>To characterize the HBV transcriptome at a single-cell resolution, Peng et al. utilized 5&#x02032; RNA sequencing and analyzed approximately 3000 hepatocytes isolated from liver-humanized FRG mice, which were stably infected with HBV and exhibited high levels of viremia. Although limited by the lack of longitudinal viral transcript data within single cells, that study suggested that the cccDNA may initiate transcription first within the X/Enhancer I domain in a stochastic manner. The accumulation of X transcripts, particularly those capable of translating functional X protein, might trigger the productive transcription of cccDNA. The transcription start site (TSS) for HBx was found near the first start codon (ATG) of the X open reading frame (ORF) [<xref rid="B22-viruses-16-01828" ref-type="bibr">22</xref>]. Earlier studies by Stadelmayer et al., using full-length 5&#x02032; RACE profiling of HBV RNAs, also revealed diversity in HBx transcripts post-infection in HepG2-NTCP cells and primary human hepatocytes (PHHs) [<xref rid="B14-viruses-16-01828" ref-type="bibr">14</xref>].</p><p>Peng et al. further showed that the transcription of HBx and related transcripts may proceed even in the presence of the Smc5/6 complex. By infecting PHHs with a virus bearing a stop codon mutation (residue 8) in HBx, they conducted 5&#x02032; single-cell sequencing 7 days after infection and found the majority of viral transcripts were from the HBx/enhancer I domain, suggesting that the initiation of HBx transcription occurs irrespective to the presence or absence of the SMC5/6 complex and before viral structural gene transcription [<xref rid="B22-viruses-16-01828" ref-type="bibr">22</xref>]. The exact mechanism underlying HBx transcription remains unclear, though G-quadruplexes (G4s) in the HBx-related regions and nucleosome occupancy have been proposed to play a role [<xref rid="B25-viruses-16-01828" ref-type="bibr">25</xref>,<xref rid="B26-viruses-16-01828" ref-type="bibr">26</xref>]. Interestingly, HBx transcripts were detected as early as 4 h post-infection in PHHs and were maintained at comparable levels within the first 24 h, even when cccDNA was barely detectable [<xref rid="B27-viruses-16-01828" ref-type="bibr">27</xref>]. Further studies are needed to determine whether any HBx transcripts are enclosed within the viral nucleocapsid. In vivo, liver cells exhibit transcriptome-wide and proteomic zonation [<xref rid="B28-viruses-16-01828" ref-type="bibr">28</xref>,<xref rid="B29-viruses-16-01828" ref-type="bibr">29</xref>], but whether liver zonation&#x02014;characterized by the distinct expression of liver transcription factors in different zones&#x02014;affects HBV transcription is largely unknown.</p></sec><sec id="sec2dot2-viruses-16-01828"><title>2.2. Coordinated HBV cccDNA Transcription in Single Cells</title><p>HBV transcripts can originate from both cccDNA and integrated viral DNA fragments [<xref rid="B30-viruses-16-01828" ref-type="bibr">30</xref>,<xref rid="B31-viruses-16-01828" ref-type="bibr">31</xref>]. As mentioned earlier, HBV cccDNA serves as the template for all viral transcripts, while integrated HBV can transcribe the 2.4 kb, 2.1 kb, and 0.7 kb transcripts [<xref rid="B32-viruses-16-01828" ref-type="bibr">32</xref>,<xref rid="B33-viruses-16-01828" ref-type="bibr">33</xref>]. In liver-humanized FRG mice infected with HBV at the plateau stage of viral titer, Peng et al. showed that over 99% of viral transcripts were derived from cccDNA. Quantitative analysis of the 3.5 kb and 2.1 kb transcripts by 5&#x02032; RNA sequencing of hepatocytes from these mice suggested that these two transcripts exhibited coordinated expression at the single-cell level [<xref rid="B22-viruses-16-01828" ref-type="bibr">22</xref>]. Similarly, in patients with a highly active HBV infection, Gustaf et al. reported that the viral transcripts for HBsAg and HBcAg were correlated [<xref rid="B34-viruses-16-01828" ref-type="bibr">34</xref>].</p><p>Previous studies have shown that HBV-infected hepatocytes contain only a few cccDNA molecules [<xref rid="B13-viruses-16-01828" ref-type="bibr">13</xref>,<xref rid="B35-viruses-16-01828" ref-type="bibr">35</xref>,<xref rid="B36-viruses-16-01828" ref-type="bibr">36</xref>]. In a given cell containing two or more cccDNA, whether the cccDNA molecules support transcription from all promoters simultaneously or a cccDNA only supports transcription from a subset of its promoters while the generation of all transcripts needs different cccDNA is a question important for understanding the dynamics of HBV infection [<xref rid="B36-viruses-16-01828" ref-type="bibr">36</xref>,<xref rid="B37-viruses-16-01828" ref-type="bibr">37</xref>,<xref rid="B38-viruses-16-01828" ref-type="bibr">38</xref>]. By using sequence alignment of viral transcripts from the cccDNA of different HBV genotypes (A/D), Peng et al. demonstrated that, in individual hepatocytes from liver-humanized FRG mice infected with both genotypes, cccDNA molecules could transcribe, from separate molecules, either all viral transcripts or transcripts primarily from the X domain without a significant expression of structural genes. Particularly in actively infected cells, different cccDNA molecules showed a highly coordinated pattern of viral transcription at the single-cell level [<xref rid="B22-viruses-16-01828" ref-type="bibr">22</xref>]. The exact mechanism by which cccDNA achieves coordinated transcription is unclear. Kornyeyev et al. reported that the HBx protein is diffusely distributed throughout the nucleus without a discernible localization pattern, suggesting that the diffused HBx may coordinate productive transcription across different cccDNA molecules within a cell [<xref rid="B39-viruses-16-01828" ref-type="bibr">39</xref>].</p><p>Despite the apparent coordination of cccDNA transcription in single cells, human liver samples, especially those from HBeAg-negative patients, reveal distinct or even exclusive expression patterns of HBsAg and HBV core protein in infected cells [<xref rid="B40-viruses-16-01828" ref-type="bibr">40</xref>,<xref rid="B41-viruses-16-01828" ref-type="bibr">41</xref>,<xref rid="B42-viruses-16-01828" ref-type="bibr">42</xref>]. Abhishek et al. used a four-plex immunofluorescence assay to analyze biopsies from both HBeAg-positive and HBeAg-negative patients [<xref rid="B42-viruses-16-01828" ref-type="bibr">42</xref>]. They observed diffuse staining patterns of individual HBV core-positive cells and foci of HBsAg-positive cells, with hepatocytes positive for both HBV core and HBsAg being rare. Notably, HBeAg-negative patients exhibited a predominance of HBsAg-positive/HBV core-negative cells, with HBsAg staining indicating patches of clonal expansion. This phenomenon is likely due to HBsAg originating predominantly from integrated HBV [<xref rid="B33-viruses-16-01828" ref-type="bibr">33</xref>,<xref rid="B42-viruses-16-01828" ref-type="bibr">42</xref>].</p></sec><sec id="sec2dot3-viruses-16-01828"><title>2.3. Transcription of Inactive cccDNA and Implications for Therapy</title><p>In patients with chronic HBV infection, some individuals exhibit low-level viremia or enter a state known as occult HBV infection (OBI), characterized by low levels of HBV cccDNA in hepatocytes and minimal or undetectable HBV RNA transcription [<xref rid="B43-viruses-16-01828" ref-type="bibr">43</xref>,<xref rid="B44-viruses-16-01828" ref-type="bibr">44</xref>]. Transcriptionally inactive cccDNA has also been identified in patients who also had HIV and had undergone long-term treatment with NUCs, as evaluated through droplet digital PCR (ddPCR) using single-cell laser capture microdissection (scLCM) [<xref rid="B19-viruses-16-01828" ref-type="bibr">19</xref>,<xref rid="B20-viruses-16-01828" ref-type="bibr">20</xref>,<xref rid="B23-viruses-16-01828" ref-type="bibr">23</xref>]. Balaagopal et al. quantified cccDNA and pgRNA in approximately 2080 single hepatocytes, finding that longer NUC treatment durations often correlated with a higher proportion of hepatocytes exhibiting inactive viral transcription [<xref rid="B20-viruses-16-01828" ref-type="bibr">20</xref>]. In line with these studies, Kim et al. found that the pgRNA transcripts became undetectable after 24 weeks of TAF therapy; however, the S and X transcripts showed no significant changes [<xref rid="B45-viruses-16-01828" ref-type="bibr">45</xref>]. Notably, Thio et al. reported that, among persistently HBeAg-negative patients with HBV, 23% to 56% of the infected hepatocytes were viral transcription inactive, a proportion that was higher than that observed in HBeAg-positive patients with HBV. Furthermore, the percentage of viral transcription active cells significantly declined following NUC treatment [<xref rid="B23-viruses-16-01828" ref-type="bibr">23</xref>]. However, the discontinuation of NUC treatment typically results in a viral rebound, even in patients who had been on the treatment for years and showed no detectable HBV in their blood before cessation [<xref rid="B3-viruses-16-01828" ref-type="bibr">3</xref>,<xref rid="B46-viruses-16-01828" ref-type="bibr">46</xref>]. The kinetics of viral rebound vary among patients, indicating different patterns of viral replication and spread within the liver.</p><p>The existence of transcriptionally inactive cccDNA has significant implications for clinical practice and drug development. Most current investigational drugs, including the most advanced candidates, result in viral relapse in the majority of patients after treatment cessation [<xref rid="B47-viruses-16-01828" ref-type="bibr">47</xref>,<xref rid="B48-viruses-16-01828" ref-type="bibr">48</xref>,<xref rid="B49-viruses-16-01828" ref-type="bibr">49</xref>]. However, assessing transcriptionally inactive or non-productive, latent cccDNA and its reactivation in human patients remains challenging mainly due to the limited availability of liver biopsy samples and the shortage of technology for dissecting the latent cccDNA with minimal or no structural gene transcription. In animal studies, Allweiss et al. demonstrated that suppressed cccDNA transcription, marked by the presence of Smc5/6 in the infected cells, could be maintained by blocking viral entry [<xref rid="B50-viruses-16-01828" ref-type="bibr">50</xref>]. Also, in liver-humanized mice, by using 5&#x02032; single-cell sequencing of HBV transcripts, Peng et al. recently showed a small proportion of hepatocytes harboring cccDNA with only low levels of HBx-related RNAs from the HBV X/enhancer I domain but no transcripts for HBV structural genes. After 4 weeks of combined treatment with a neutralizing anti-preS1 antibody and PEG-IFN&#x003b1;, the ratio of these non-productive hepatocytes increased from 16% to 32%, accompanied by decreased levels of viral structural genes [<xref rid="B22-viruses-16-01828" ref-type="bibr">22</xref>].</p><p>As previously mentioned, the proportion of infected cells containing transcriptionally inactive cccDNA increases during NUC treatment. However, even under NUC treatment, viral amplification and spread are only suppressed to a low but non-negligible level [<xref rid="B51-viruses-16-01828" ref-type="bibr">51</xref>,<xref rid="B52-viruses-16-01828" ref-type="bibr">52</xref>]. Considering the quasispecies nature of HBV infection, cross-activation of cccDNA within individual cells may still occur, generating infectious viruses even if the original variants alone are defective. This continuous infection&#x02013;reinfection cycle may be a key mechanism of persistent infection. Indeed, the cross-activation of HBV variants has been observed in cell cultures [<xref rid="B22-viruses-16-01828" ref-type="bibr">22</xref>]. HBx gene expression from the integrated viral genome may also facilitate reactivation [<xref rid="B32-viruses-16-01828" ref-type="bibr">32</xref>]. Given that hepatocyte renewal is highly dependent on ploidy, with diploid cells showing a more than seven-fold higher annual birth rate compared with polyploid cells [<xref rid="B24-viruses-16-01828" ref-type="bibr">24</xref>], inactive cccDNA residing in polyploid hepatocytes may persist long term and serve as a source of reactivation. Blocking the continuous cycle of HBV infection in the liver could alter the course of chronic hepatitis B (CHB), but further clinical studies are needed to determine how best to combine various therapies for different populations of patients with HBV. Given the added divergence in HBV-infected hepatocytes, including changes in metabolism and gene expression, antiviral interventions such as entry inhibitors, which are free from concerns about membrane transportation and intracellular pharmacological differences, may be particularly suited for combination therapies aimed at shortening the duration of curative treatment.</p></sec></sec><sec id="sec3-viruses-16-01828"><title>3. New Research Tools for Future Studies</title><p>Despite significant progress in single-cell transcriptomic research on HBV, many questions remain unanswered. New technologies are under development but have already begun to offer fresh insights into HBV infection. Some of these include the following:</p><sec id="sec3dot1-viruses-16-01828"><title>3.1. Spatial Transcriptomics</title><p>Hepatocytes exhibit spatial heterogeneity and zonation along the portal&#x02013;central axis within the liver lobule, with both transcriptomic and proteomic zonation observed in liver cells [<xref rid="B28-viruses-16-01828" ref-type="bibr">28</xref>,<xref rid="B29-viruses-16-01828" ref-type="bibr">29</xref>]. Integrating spatial information to analyze the distribution and interactions between different cell types during HBV infection could lead to a better understanding of the crosstalk between HBV and host cells [<xref rid="B53-viruses-16-01828" ref-type="bibr">53</xref>].</p></sec><sec id="sec3dot2-viruses-16-01828"><title>3.2. Long-Read Sequencing Technologies</title><p>HBV transcripts contain splice variants, and methods such as ddPCR or 5&#x02032; sequencing, which focus on short fragments, are limited in their ability to quantitatively assess viral transcript variants from cccDNA or integrated DNA in single cells. Long-read sequencing technologies enable a more precise analysis of viral RNA structures and complex gene regulatory networks [<xref rid="B33-viruses-16-01828" ref-type="bibr">33</xref>].</p></sec><sec id="sec3dot3-viruses-16-01828"><title>3.3. Multi-Omics Integration</title><p>Integrating single-cell DNA sequencing, transcriptomics, and proteomics could enhance our understanding of the molecular mechanisms underlying HBV infection [<xref rid="B41-viruses-16-01828" ref-type="bibr">41</xref>,<xref rid="B42-viruses-16-01828" ref-type="bibr">42</xref>]. For example, multi-omics analysis may provide deeper insights into the nature of HBsAg-negative/HBV core-positive hepatocytes in patients [<xref rid="B42-viruses-16-01828" ref-type="bibr">42</xref>].</p></sec><sec id="sec3dot4-viruses-16-01828"><title>3.4. Deep Learning</title><p>Omics and multi-omics studies generate vast amounts of data. Advanced data analysis approaches, such as deep learning, could accelerate the extraction of valuable insights from these large datasets [<xref rid="B54-viruses-16-01828" ref-type="bibr">54</xref>,<xref rid="B55-viruses-16-01828" ref-type="bibr">55</xref>,<xref rid="B56-viruses-16-01828" ref-type="bibr">56</xref>], driving forward our understanding of HBV infection.</p></sec></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Writing&#x02014;original draft preparation, B.P.; writing&#x02014;review and editing, W.L., B.P. and L.P.; visualization, B.P. and W.L.; supervision, W.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>Wenhui Li is a scientific co-founder of Huahui Health Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. </p></notes><ref-list><title>References</title><ref id="B1-viruses-16-01828"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dienstag</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Benefits and risks of nucleoside analog therapy for hepatitis B</article-title><source>Hepatology</source><year>2009</year><volume>49</volume><issue>(Suppl. 5)</issue><fpage>S112</fpage><lpage>S121</lpage><pub-id pub-id-type="doi">10.1002/hep.22920</pub-id><pub-id pub-id-type="pmid">19399795</pub-id>
</element-citation></ref><ref id="B2-viruses-16-01828"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fung</surname><given-names>J.</given-names></name>
<name><surname>Lai</surname><given-names>C.L.</given-names></name>
<name><surname>Seto</surname><given-names>W.K.</given-names></name>
<name><surname>Yuen</surname><given-names>M.F.</given-names></name>
</person-group><article-title>Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B</article-title><source>J. Antimicrob. Chemother.</source><year>2011</year><volume>66</volume><fpage>2715</fpage><lpage>2725</lpage><pub-id pub-id-type="doi">10.1093/jac/dkr388</pub-id><pub-id pub-id-type="pmid">21965435</pub-id>
</element-citation></ref><ref id="B3-viruses-16-01828"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chevaliez</surname><given-names>S.</given-names></name>
<name><surname>H&#x000e9;zode</surname><given-names>C.</given-names></name>
<name><surname>Bahrami</surname><given-names>S.</given-names></name>
<name><surname>Grare</surname><given-names>M.</given-names></name>
<name><surname>Pawlotsky</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely</article-title><source>J. Hepatol.</source><year>2013</year><volume>58</volume><fpage>676</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2012.11.039</pub-id><pub-id pub-id-type="pmid">23219442</pub-id>
</element-citation></ref><ref id="B4-viruses-16-01828"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cattaneo</surname><given-names>R.</given-names></name>
<name><surname>Will</surname><given-names>H.</given-names></name>
<name><surname>Schaller</surname><given-names>H.</given-names></name>
</person-group><article-title>Hepatitis B virus transcription in the infected liver</article-title><source>EMBO J.</source><year>1984</year><volume>3</volume><fpage>2191</fpage><lpage>2196</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1984.tb02113.x</pub-id><pub-id pub-id-type="pmid">6092066</pub-id>
</element-citation></ref><ref id="B5-viruses-16-01828"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seeger</surname><given-names>C.</given-names></name>
<name><surname>Mason</surname><given-names>W.S.</given-names></name>
</person-group><article-title>Molecular biology of hepatitis B virus infection</article-title><source>Virology</source><year>2015</year><volume>479&#x02013;480</volume><fpage>672</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2015.02.031</pub-id><pub-id pub-id-type="pmid">25759099</pub-id>
</element-citation></ref><ref id="B6-viruses-16-01828"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martinez</surname><given-names>M.G.</given-names></name>
<name><surname>Boyd</surname><given-names>A.</given-names></name>
<name><surname>Combe</surname><given-names>E.</given-names></name>
<name><surname>Testoni</surname><given-names>B.</given-names></name>
<name><surname>Zoulim</surname><given-names>F.</given-names></name>
</person-group><article-title>Covalently closed circular DNA: The ultimate therapeutic target for curing HBV infections</article-title><source>J. Hepatol.</source><year>2021</year><volume>75</volume><fpage>706</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2021.05.013</pub-id><pub-id pub-id-type="pmid">34051332</pub-id>
</element-citation></ref><ref id="B7-viruses-16-01828"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kramvis</surname><given-names>A.</given-names></name>
<name><surname>Chang</surname><given-names>K.M.</given-names></name>
<name><surname>Dandri</surname><given-names>M.</given-names></name>
<name><surname>Farci</surname><given-names>P.</given-names></name>
<name><surname>Glebe</surname><given-names>D.</given-names></name>
<name><surname>Hu</surname><given-names>J.</given-names></name>
<name><surname>Janssen</surname><given-names>H.L.A.</given-names></name>
<name><surname>Lau</surname><given-names>D.T.Y.</given-names></name>
<name><surname>Penicaud</surname><given-names>C.</given-names></name>
<name><surname>Pollicino</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>A roadmap for serum biomarkers for hepatitis B virus: Current status and future outlook</article-title><source>Nat. Rev. Gastroenterol. Hepatol.</source><year>2022</year><volume>19</volume><fpage>727</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1038/s41575-022-00649-z</pub-id><pub-id pub-id-type="pmid">35859026</pub-id>
</element-citation></ref><ref id="B8-viruses-16-01828"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tsuge</surname><given-names>M.</given-names></name>
<name><surname>Hiraga</surname><given-names>N.</given-names></name>
<name><surname>Akiyama</surname><given-names>R.</given-names></name>
<name><surname>Tanaka</surname><given-names>S.</given-names></name>
<name><surname>Matsushita</surname><given-names>M.</given-names></name>
<name><surname>Mitsui</surname><given-names>F.</given-names></name>
<name><surname>Abe</surname><given-names>H.</given-names></name>
<name><surname>Kitamura</surname><given-names>S.</given-names></name>
<name><surname>Hatakeyama</surname><given-names>T.</given-names></name>
<name><surname>Kimura</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice</article-title><source>J. Gen. Virol.</source><year>2010</year><volume>91</volume><issue-part>Pt 7</issue-part><fpage>1854</fpage><lpage>1864</lpage><pub-id pub-id-type="doi">10.1099/vir.0.019224-0</pub-id><pub-id pub-id-type="pmid">20219897</pub-id>
</element-citation></ref><ref id="B9-viruses-16-01828"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lucifora</surname><given-names>J.</given-names></name>
<name><surname>Arzberger</surname><given-names>S.</given-names></name>
<name><surname>Durantel</surname><given-names>D.</given-names></name>
<name><surname>Belloni</surname><given-names>L.</given-names></name>
<name><surname>Strubin</surname><given-names>M.</given-names></name>
<name><surname>Levrero</surname><given-names>M.</given-names></name>
<name><surname>Zoulim</surname><given-names>F.</given-names></name>
<name><surname>Hantz</surname><given-names>O.</given-names></name>
<name><surname>Protzer</surname><given-names>U.</given-names></name>
</person-group><article-title>Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection</article-title><source>J. Hepatol.</source><year>2011</year><volume>55</volume><fpage>996</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2011.02.015</pub-id><pub-id pub-id-type="pmid">21376091</pub-id>
</element-citation></ref><ref id="B10-viruses-16-01828"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Decorsi&#x000e8;re</surname><given-names>A.</given-names></name>
<name><surname>Mueller</surname><given-names>H.</given-names></name>
<name><surname>van Breugel</surname><given-names>P.C.</given-names></name>
<name><surname>Abdul</surname><given-names>F.</given-names></name>
<name><surname>Gerossier</surname><given-names>L.</given-names></name>
<name><surname>Beran</surname><given-names>R.K.</given-names></name>
<name><surname>Livingston</surname><given-names>C.M.</given-names></name>
<name><surname>Niu</surname><given-names>C.</given-names></name>
<name><surname>Fletcher</surname><given-names>S.P.</given-names></name>
<name><surname>Hantz</surname><given-names>O.</given-names></name>
<etal/>
</person-group><article-title>Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor</article-title><source>Nature</source><year>2016</year><volume>531</volume><fpage>386</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1038/nature17170</pub-id><pub-id pub-id-type="pmid">26983541</pub-id>
</element-citation></ref><ref id="B11-viruses-16-01828"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Murphy</surname><given-names>C.M.</given-names></name>
<name><surname>Xu</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>F.</given-names></name>
<name><surname>Nio</surname><given-names>K.</given-names></name>
<name><surname>Reszka-Blanco</surname><given-names>N.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Yu</surname><given-names>Y.</given-names></name>
<name><surname>Xiong</surname><given-names>Y.</given-names></name>
<name><surname>Su</surname><given-names>L.</given-names></name>
</person-group><article-title>Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication</article-title><source>Cell Rep.</source><year>2016</year><volume>16</volume><fpage>2846</fpage><lpage>2854</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.08.026</pub-id><pub-id pub-id-type="pmid">27626656</pub-id>
</element-citation></ref><ref id="B12-viruses-16-01828"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tang</surname><given-names>D.</given-names></name>
<name><surname>Zhao</surname><given-names>H.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Peng</surname><given-names>B.</given-names></name>
<name><surname>Gao</surname><given-names>Z.</given-names></name>
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<name><surname>Duan</surname><given-names>J.</given-names></name>
<name><surname>Qi</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Zhou</surname><given-names>Z.</given-names></name>
<etal/>
</person-group><article-title>Transcriptionally inactive hepatitis B virus episome DNA preferentially resides in the vicinity of chromosome 19 in 3D host genome upon infection</article-title><source>Cell Rep.</source><year>2021</year><volume>35</volume><fpage>109288</fpage><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109288</pub-id><pub-id pub-id-type="pmid">34192543</pub-id>
</element-citation></ref><ref id="B13-viruses-16-01828"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yao</surname><given-names>Q.</given-names></name>
<name><surname>Peng</surname><given-names>B.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Chen</surname><given-names>M.</given-names></name>
<name><surname>Zhou</surname><given-names>Z.</given-names></name>
<name><surname>Tang</surname><given-names>D.</given-names></name>
<name><surname>He</surname><given-names>J.</given-names></name>
<name><surname>Wu</surname><given-names>Y.</given-names></name>
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>SLF2 Interacts with the SMC5/6 Complex to Direct Hepatitis B Virus Episomal DNA to Promyelocytic Leukemia Bodies for Transcriptional Repression</article-title><source>J. Virol.</source><year>2023</year><volume>97</volume><fpage>e0032823</fpage><pub-id pub-id-type="doi">10.1128/jvi.00328-23</pub-id><pub-id pub-id-type="pmid">37338350</pub-id>
</element-citation></ref><ref id="B14-viruses-16-01828"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stadelmayer</surname><given-names>B.</given-names></name>
<name><surname>Diederichs</surname><given-names>A.</given-names></name>
<name><surname>Chapus</surname><given-names>F.</given-names></name>
<name><surname>Rivoire</surname><given-names>M.</given-names></name>
<name><surname>Neveu</surname><given-names>G.</given-names></name>
<name><surname>Alam</surname><given-names>A.</given-names></name>
<name><surname>Fraisse</surname><given-names>L.</given-names></name>
<name><surname>Carter</surname><given-names>K.</given-names></name>
<name><surname>Testoni</surname><given-names>B.</given-names></name>
<name><surname>Zoulim</surname><given-names>F.</given-names></name>
</person-group><article-title>Full-length 5&#x02019;RACE identifies all major HBV transcripts in HBV-infected hepatocytes and patient serum</article-title><source>J. Hepatol.</source><year>2020</year><volume>73</volume><fpage>40</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2020.01.028</pub-id><pub-id pub-id-type="pmid">32087349</pub-id>
</element-citation></ref><ref id="B15-viruses-16-01828"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Altinel</surname><given-names>K.</given-names></name>
<name><surname>Hashimoto</surname><given-names>K.</given-names></name>
<name><surname>Wei</surname><given-names>Y.</given-names></name>
<name><surname>Neuveut</surname><given-names>C.</given-names></name>
<name><surname>Gupta</surname><given-names>I.</given-names></name>
<name><surname>Suzuki</surname><given-names>A.M.</given-names></name>
<name><surname>Dos Santos</surname><given-names>A.</given-names></name>
<name><surname>Moreau</surname><given-names>P.</given-names></name>
<name><surname>Xia</surname><given-names>T.</given-names></name>
<name><surname>Kojima</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Single-Nucleotide Resolution Mapping of Hepatitis B Virus Promoters in Infected Human Livers and Hepatocellular Carcinoma</article-title><source>J. Virol.</source><year>2016</year><volume>90</volume><fpage>10811</fpage><lpage>10822</lpage><pub-id pub-id-type="doi">10.1128/JVI.01625-16</pub-id><pub-id pub-id-type="pmid">27681123</pub-id>
</element-citation></ref><ref id="B16-viruses-16-01828"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tang</surname><given-names>F.</given-names></name>
<name><surname>Barbacioru</surname><given-names>C.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Nordman</surname><given-names>E.</given-names></name>
<name><surname>Lee</surname><given-names>C.</given-names></name>
<name><surname>Xu</surname><given-names>N.</given-names></name>
<name><surname>Wang</surname><given-names>X.</given-names></name>
<name><surname>Bodeau</surname><given-names>J.</given-names></name>
<name><surname>Tuch</surname><given-names>B.B.</given-names></name>
<name><surname>Siddiqui</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>mRNA-Seq whole-transcriptome analysis of a single cell</article-title><source>Nat. Methods</source><year>2009</year><volume>6</volume><fpage>377</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1315</pub-id><pub-id pub-id-type="pmid">19349980</pub-id>
</element-citation></ref><ref id="B17-viruses-16-01828"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cole</surname><given-names>C.</given-names></name>
<name><surname>Byrne</surname><given-names>A.</given-names></name>
<name><surname>Beaudin</surname><given-names>A.E.</given-names></name>
<name><surname>Forsberg</surname><given-names>E.C.</given-names></name>
<name><surname>Vollmers</surname><given-names>C.</given-names></name>
</person-group><article-title>Tn5Prime, a Tn5 based 5&#x02019; capture method for single cell RNA-seq</article-title><source>Nucleic Acids Res.</source><year>2018</year><volume>46</volume><fpage>e62</fpage><pub-id pub-id-type="doi">10.1093/nar/gky182</pub-id><pub-id pub-id-type="pmid">29548006</pub-id>
</element-citation></ref><ref id="B18-viruses-16-01828"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beliveau</surname><given-names>B.J.</given-names></name>
<name><surname>Boettiger</surname><given-names>A.N.</given-names></name>
<name><surname>Avenda&#x000f1;o</surname><given-names>M.S.</given-names></name>
<name><surname>Jungmann</surname><given-names>R.</given-names></name>
<name><surname>McCole</surname><given-names>R.B.</given-names></name>
<name><surname>Joyce</surname><given-names>E.F.</given-names></name>
<name><surname>Kim-Kiselak</surname><given-names>C.</given-names></name>
<name><surname>Bantignies</surname><given-names>F.</given-names></name>
<name><surname>Fonseka</surname><given-names>C.Y.</given-names></name>
<name><surname>Erceg</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Single-molecule super-resolution imaging of chromosomes and in situ haplotype visualization using Oligopaint FISH probes</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>7147</fpage><pub-id pub-id-type="doi">10.1038/ncomms8147</pub-id><pub-id pub-id-type="pmid">25962338</pub-id>
</element-citation></ref><ref id="B19-viruses-16-01828"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balagopal</surname><given-names>A.</given-names></name>
<name><surname>Hwang</surname><given-names>H.S.</given-names></name>
<name><surname>Grudda</surname><given-names>T.</given-names></name>
<name><surname>Quinn</surname><given-names>J.</given-names></name>
<name><surname>Sterling</surname><given-names>R.K.</given-names></name>
<name><surname>Sulkowski</surname><given-names>M.S.</given-names></name>
<name><surname>Thio</surname><given-names>C.L.</given-names></name>
</person-group><article-title>Single Hepatocyte Hepatitis B Virus Transcriptional Landscape in HIV Coinfection</article-title><source>J. Infect. Dis.</source><year>2020</year><volume>221</volume><fpage>1462</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiz607</pub-id><pub-id pub-id-type="pmid">31740931</pub-id>
</element-citation></ref><ref id="B20-viruses-16-01828"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Balagopal</surname><given-names>A.</given-names></name>
<name><surname>Grudda</surname><given-names>T.</given-names></name>
<name><surname>Ribeiro</surname><given-names>R.M.</given-names></name>
<name><surname>Saad</surname><given-names>Y.S.</given-names></name>
<name><surname>Hwang</surname><given-names>H.S.</given-names></name>
<name><surname>Quinn</surname><given-names>J.</given-names></name>
<name><surname>Murphy</surname><given-names>M.</given-names></name>
<name><surname>Ward</surname><given-names>K.</given-names></name>
<name><surname>Sterling</surname><given-names>R.K.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Single hepatocytes show persistence and transcriptional inactivity of hepatitis B</article-title><source>JCI Insight</source><year>2020</year><volume>5</volume><fpage>140584</fpage><pub-id pub-id-type="doi">10.1172/jci.insight.140584</pub-id><pub-id pub-id-type="pmid">33004689</pub-id>
</element-citation></ref><ref id="B21-viruses-16-01828"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Lu</surname><given-names>W.</given-names></name>
<name><surname>Zheng</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Bai</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>L.</given-names></name>
<name><surname>Feng</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Yuan</surname><given-names>Z.</given-names></name>
</person-group><article-title>In situ analysis of intrahepatic virological events in chronic hepatitis B virus infection</article-title><source>J. Clin. Investig.</source><year>2016</year><volume>126</volume><fpage>1079</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1172/JCI83339</pub-id><pub-id pub-id-type="pmid">26901811</pub-id>
</element-citation></ref><ref id="B22-viruses-16-01828"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Peng</surname><given-names>B.</given-names></name>
<name><surname>Jing</surname><given-names>Z.</given-names></name>
<name><surname>Zhou</surname><given-names>Z.</given-names></name>
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<name><surname>Guo</surname><given-names>G.</given-names></name>
<name><surname>Tan</surname><given-names>Z.</given-names></name>
<name><surname>Diao</surname><given-names>Y.</given-names></name>
<name><surname>Yao</surname><given-names>Q.</given-names></name>
<name><surname>Ping</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<etal/>
</person-group><article-title>Nonproductive Hepatitis B Virus Covalently Closed Circular DNA Generates HBx-Related Transcripts from the HBx/Enhancer I Region and Acquires Reactivation by Superinfection in Single Cells</article-title><source>J. Virol.</source><year>2023</year><volume>97</volume><fpage>e0171722</fpage><pub-id pub-id-type="doi">10.1128/jvi.01717-22</pub-id><pub-id pub-id-type="pmid">36475867</pub-id>
</element-citation></ref><ref id="B23-viruses-16-01828"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thio</surname><given-names>C.L.</given-names></name>
<name><surname>Taddese</surname><given-names>M.</given-names></name>
<name><surname>Saad</surname><given-names>Y.</given-names></name>
<name><surname>Zambo</surname><given-names>K.</given-names></name>
<name><surname>Ribeiro</surname><given-names>R.M.</given-names></name>
<name><surname>Grudda</surname><given-names>T.</given-names></name>
<name><surname>Sulkowski</surname><given-names>M.S.</given-names></name>
<name><surname>Sterling</surname><given-names>R.K.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Young</surname><given-names>E.D.</given-names></name>
<etal/>
</person-group><article-title>Hepatitis B e Antigen-Negative Single Hepatocyte Analysis Shows Transcriptional Silencing and Slow Decay of Infected Cells With Treatment</article-title><source>J. Infect. Dis.</source><year>2023</year><volume>228</volume><fpage>1219</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiad124</pub-id><pub-id pub-id-type="pmid">37129258</pub-id>
</element-citation></ref><ref id="B24-viruses-16-01828"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heinke</surname><given-names>P.</given-names></name>
<name><surname>Rost</surname><given-names>F.</given-names></name>
<name><surname>Rode</surname><given-names>J.</given-names></name>
<name><surname>Trus</surname><given-names>P.</given-names></name>
<name><surname>Simonova</surname><given-names>I.</given-names></name>
<name><surname>L&#x000e1;z&#x000e1;r</surname><given-names>E.</given-names></name>
<name><surname>Feddema</surname><given-names>J.</given-names></name>
<name><surname>Welsch</surname><given-names>T.</given-names></name>
<name><surname>Alkass</surname><given-names>K.</given-names></name>
<name><surname>Salehpour</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Diploid hepatocytes drive physiological liver renewal in adult humans</article-title><source>Cell Syst.</source><year>2022</year><volume>13</volume><fpage>499</fpage><lpage>507.e12</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2022.05.001</pub-id><pub-id pub-id-type="pmid">35649419</pub-id>
</element-citation></ref><ref id="B25-viruses-16-01828"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prescott</surname><given-names>N.A.</given-names></name>
<name><surname>Mansisidor</surname><given-names>A.</given-names></name>
<name><surname>Bram</surname><given-names>Y.</given-names></name>
<name><surname>Lemmon</surname><given-names>A.A.</given-names></name>
<name><surname>Lim</surname><given-names>C.</given-names></name>
<name><surname>Risca</surname><given-names>V.I.</given-names></name>
<name><surname>Schwartz</surname><given-names>R.E.</given-names></name>
<name><surname>David</surname><given-names>Y.</given-names></name>
</person-group><article-title>A nucleosome switch primes Hepatitis B Virus infection</article-title><source>bioRxiv</source><year>2023</year><pub-id pub-id-type="doi">10.1101/2023.03.03.531011</pub-id></element-citation></ref><ref id="B26-viruses-16-01828"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Giraud</surname><given-names>G.</given-names></name>
<name><surname>Rod&#x000e0;</surname><given-names>M.</given-names></name>
<name><surname>Huchon</surname><given-names>P.</given-names></name>
<name><surname>Michelet</surname><given-names>M.</given-names></name>
<name><surname>Maadadi</surname><given-names>S.</given-names></name>
<name><surname>Jutzi</surname><given-names>D.</given-names></name>
<name><surname>Montserret</surname><given-names>R.</given-names></name>
<name><surname>Ruepp</surname><given-names>M.D.</given-names></name>
<name><surname>Parent</surname><given-names>R.</given-names></name>
<name><surname>Combet</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>G-quadruplexes control hepatitis B virus replication by promoting cccDNA transcription and phase separation in hepatocytes</article-title><source>Nucleic Acids Res.</source><year>2024</year><volume>52</volume><fpage>2290</fpage><lpage>2305</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad1200</pub-id><pub-id pub-id-type="pmid">38113270</pub-id>
</element-citation></ref><ref id="B27-viruses-16-01828"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niu</surname><given-names>C.</given-names></name>
<name><surname>Livingston</surname><given-names>C.M.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Beran</surname><given-names>R.K.</given-names></name>
<name><surname>Daffis</surname><given-names>S.</given-names></name>
<name><surname>Ramakrishnan</surname><given-names>D.</given-names></name>
<name><surname>Burdette</surname><given-names>D.</given-names></name>
<name><surname>Peiser</surname><given-names>L.</given-names></name>
<name><surname>Salas</surname><given-names>E.</given-names></name>
<name><surname>Ramos</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0169648</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0169648</pub-id><pub-id pub-id-type="pmid">28095508</pub-id>
</element-citation></ref><ref id="B28-viruses-16-01828"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aizarani</surname><given-names>N.</given-names></name>
<name><surname>Saviano</surname><given-names>A.</given-names></name>
<name><surname>Sagar</surname></name>
<name><surname>Mailly</surname><given-names>L.</given-names></name>
<name><surname>Durand</surname><given-names>S.</given-names></name>
<name><surname>Herman</surname><given-names>J.S.</given-names></name>
<name><surname>Pessaux</surname><given-names>P.</given-names></name>
<name><surname>Baumert</surname><given-names>T.F.</given-names></name>
<name><surname>Gr&#x000fc;n</surname><given-names>D.</given-names></name>
</person-group><article-title>A human liver cell atlas reveals heterogeneity and epithelial progenitors</article-title><source>Nature</source><year>2019</year><volume>572</volume><fpage>199</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1373-2</pub-id><pub-id pub-id-type="pmid">31292543</pub-id>
</element-citation></ref><ref id="B29-viruses-16-01828"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rosenberger</surname><given-names>F.A.</given-names></name>
<name><surname>Thielert</surname><given-names>M.</given-names></name>
<name><surname>Strauss</surname><given-names>M.T.</given-names></name>
<name><surname>Schweizer</surname><given-names>L.</given-names></name>
<name><surname>Ammar</surname><given-names>C.</given-names></name>
<name><surname>M&#x000e4;dler</surname><given-names>S.C.</given-names></name>
<name><surname>Metousis</surname><given-names>A.</given-names></name>
<name><surname>Skowronek</surname><given-names>P.</given-names></name>
<name><surname>Wahle</surname><given-names>M.</given-names></name>
<name><surname>Madden</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Spatial single-cell mass spectrometry defines zonation of the hepatocyte proteome</article-title><source>Nat. Methods</source><year>2023</year><volume>20</volume><fpage>1530</fpage><lpage>1536</lpage><pub-id pub-id-type="doi">10.1038/s41592-023-02007-6</pub-id><pub-id pub-id-type="pmid">37783884</pub-id>
</element-citation></ref><ref id="B30-viruses-16-01828"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tu</surname><given-names>T.</given-names></name>
<name><surname>Budzinska</surname><given-names>M.A.</given-names></name>
<name><surname>Shackel</surname><given-names>N.A.</given-names></name>
<name><surname>Urban</surname><given-names>S.</given-names></name>
</person-group><article-title>HBV DNA Integration: Molecular Mechanisms and Clinical Implications</article-title><source>Viruses</source><year>2017</year><volume>9</volume><elocation-id>75</elocation-id><pub-id pub-id-type="doi">10.3390/v9040075</pub-id><pub-id pub-id-type="pmid">28394272</pub-id>
</element-citation></ref><ref id="B31-viruses-16-01828"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zoulim</surname><given-names>F.</given-names></name>
<name><surname>Chen</surname><given-names>P.J.</given-names></name>
<name><surname>Dandri</surname><given-names>M.</given-names></name>
<name><surname>Kennedy</surname><given-names>P.T.</given-names></name>
<name><surname>Seeger</surname><given-names>C.</given-names></name>
</person-group><article-title>Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome</article-title><source>J. Hepatol.</source><year>2024</year><volume>81</volume><fpage>1087</fpage><lpage>1099</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2024.06.037</pub-id><pub-id pub-id-type="pmid">38971531</pub-id>
</element-citation></ref><ref id="B32-viruses-16-01828"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wooddell</surname><given-names>C.I.</given-names></name>
<name><surname>Yuen</surname><given-names>M.F.</given-names></name>
<name><surname>Chan</surname><given-names>H.L.</given-names></name>
<name><surname>Gish</surname><given-names>R.G.</given-names></name>
<name><surname>Locarnini</surname><given-names>S.A.</given-names></name>
<name><surname>Chavez</surname><given-names>D.</given-names></name>
<name><surname>Ferrari</surname><given-names>C.</given-names></name>
<name><surname>Given</surname><given-names>B.D.</given-names></name>
<name><surname>Hamilton</surname><given-names>J.</given-names></name>
<name><surname>Kanner</surname><given-names>S.B.</given-names></name>
<etal/>
</person-group><article-title>RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg</article-title><source>Sci. Transl. Med.</source><year>2017</year><volume>9</volume><fpage>eaan0241</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aan0241</pub-id><pub-id pub-id-type="pmid">28954926</pub-id>
</element-citation></ref><ref id="B33-viruses-16-01828"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Buuren</surname><given-names>N.</given-names></name>
<name><surname>Ramirez</surname><given-names>R.</given-names></name>
<name><surname>Soulette</surname><given-names>C.</given-names></name>
<name><surname>Suri</surname><given-names>V.</given-names></name>
<name><surname>Han</surname><given-names>D.</given-names></name>
<name><surname>May</surname><given-names>L.</given-names></name>
<name><surname>Turner</surname><given-names>S.</given-names></name>
<name><surname>Parvangada</surname><given-names>P.C.</given-names></name>
<name><surname>Martin</surname><given-names>R.</given-names></name>
<name><surname>Chan</surname><given-names>H.L.Y.</given-names></name>
<etal/>
</person-group><article-title>Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B</article-title><source>JHEP Rep.</source><year>2022</year><volume>4</volume><fpage>100449</fpage><pub-id pub-id-type="doi">10.1016/j.jhepr.2022.100449</pub-id><pub-id pub-id-type="pmid">35295767</pub-id>
</element-citation></ref><ref id="B34-viruses-16-01828"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rydell</surname><given-names>G.E.</given-names></name>
<name><surname>Prakash</surname><given-names>K.</given-names></name>
<name><surname>Larsson</surname><given-names>S.B.</given-names></name>
<name><surname>Skoglund</surname><given-names>C.</given-names></name>
<name><surname>Ringlander</surname><given-names>J.</given-names></name>
<name><surname>Andersson</surname><given-names>M.E.</given-names></name>
<name><surname>Castedal</surname><given-names>M.</given-names></name>
<name><surname>Norder</surname><given-names>H.</given-names></name>
<name><surname>Lindh</surname><given-names>M.</given-names></name>
</person-group><article-title>Quantification of Viral RNA in Multiple Pieces of Explant Liver Tissue Shows Distinct Focal Differences in Hepatitis B Infection</article-title><source>J. Infect. Dis.</source><year>2022</year><volume>226</volume><fpage>1036</fpage><lpage>1040</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiab469</pub-id><pub-id pub-id-type="pmid">34534318</pub-id>
</element-citation></ref><ref id="B35-viruses-16-01828"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Sohn</surname><given-names>J.A.</given-names></name>
<name><surname>Seeger</surname><given-names>C.</given-names></name>
</person-group><article-title>Distribution of Hepatitis B Virus Nuclear DNA</article-title><source>J. Virol.</source><year>2018</year><volume>92</volume><fpage>10</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1128/JVI.01391-17</pub-id></element-citation></ref><ref id="B36-viruses-16-01828"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nassal</surname><given-names>M.</given-names></name>
</person-group><article-title>HBV cccDNA: Viral persistence reservoir and key obstacle for a cure of chronic hepatitis B</article-title><source>Gut</source><year>2015</year><volume>64</volume><fpage>1972</fpage><lpage>1984</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2015-309809</pub-id><pub-id pub-id-type="pmid">26048673</pub-id>
</element-citation></ref><ref id="B37-viruses-16-01828"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Newbold</surname><given-names>J.E.</given-names></name>
<name><surname>Xin</surname><given-names>H.</given-names></name>
<name><surname>Tencza</surname><given-names>M.</given-names></name>
<name><surname>Sherman</surname><given-names>G.</given-names></name>
<name><surname>Dean</surname><given-names>J.</given-names></name>
<name><surname>Bowden</surname><given-names>S.</given-names></name>
<name><surname>Locarnini</surname><given-names>S.</given-names></name>
</person-group><article-title>The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes</article-title><source>J. Virol.</source><year>1995</year><volume>69</volume><fpage>3350</fpage><lpage>3357</lpage><pub-id pub-id-type="doi">10.1128/jvi.69.6.3350-3357.1995</pub-id><pub-id pub-id-type="pmid">7745682</pub-id>
</element-citation></ref><ref id="B38-viruses-16-01828"><label>38.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Knipe</surname><given-names>D.M.</given-names></name>
<name><surname>Howley</surname><given-names>P.</given-names></name>
</person-group><source>Fields Virology</source><edition>6th ed.</edition><publisher-name>Lippincott Williams &#x00026; Wilkins (LWW)</publisher-name><publisher-loc>Philadelphia, PA USA</publisher-loc><year>2013</year></element-citation></ref><ref id="B39-viruses-16-01828"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kornyeyev</surname><given-names>D.</given-names></name>
<name><surname>Ramakrishnan</surname><given-names>D.</given-names></name>
<name><surname>Voitenleitner</surname><given-names>C.</given-names></name>
<name><surname>Livingston</surname><given-names>C.M.</given-names></name>
<name><surname>Xing</surname><given-names>W.</given-names></name>
<name><surname>Hung</surname><given-names>M.</given-names></name>
<name><surname>Kwon</surname><given-names>H.J.</given-names></name>
<name><surname>Fletcher</surname><given-names>S.P.</given-names></name>
<name><surname>Beran</surname><given-names>R.K.</given-names></name>
</person-group><article-title>Spatiotemporal Analysis of Hepatitis B Virus X Protein in Primary Human Hepatocytes</article-title><source>J. Virol.</source><year>2019</year><volume>93</volume><fpage>10</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1128/JVI.00248-19</pub-id></element-citation></ref><ref id="B40-viruses-16-01828"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Montanari</surname><given-names>N.R.</given-names></name>
<name><surname>Ram&#x000ed;rez</surname><given-names>R.</given-names></name>
<name><surname>Aggarwal</surname><given-names>A.</given-names></name>
<name><surname>van Buuren</surname><given-names>N.</given-names></name>
<name><surname>Doukas</surname><given-names>M.</given-names></name>
<name><surname>Moon</surname><given-names>C.</given-names></name>
<name><surname>Turner</surname><given-names>S.</given-names></name>
<name><surname>Diehl</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Debes</surname><given-names>J.D.</given-names></name>
<etal/>
</person-group><article-title>Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection</article-title><source>J. Hepatol.</source><year>2022</year><volume>77</volume><fpage>332</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2022.02.016</pub-id><pub-id pub-id-type="pmid">35218813</pub-id>
</element-citation></ref><ref id="B41-viruses-16-01828"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Buuren</surname><given-names>N.</given-names></name>
<name><surname>Ramirez</surname><given-names>R.</given-names></name>
<name><surname>Turner</surname><given-names>S.</given-names></name>
<name><surname>Chen</surname><given-names>D.</given-names></name>
<name><surname>Suri</surname><given-names>V.</given-names></name>
<name><surname>Aggarwal</surname><given-names>A.</given-names></name>
<name><surname>Moon</surname><given-names>C.</given-names></name>
<name><surname>Kim</surname><given-names>S.</given-names></name>
<name><surname>Kornyeyev</surname><given-names>D.</given-names></name>
<name><surname>Bui</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection</article-title><source>JHEP Rep.</source><year>2022</year><volume>4</volume><fpage>100388</fpage><pub-id pub-id-type="doi">10.1016/j.jhepr.2021.100388</pub-id><pub-id pub-id-type="pmid">34950863</pub-id>
</element-citation></ref><ref id="B42-viruses-16-01828"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aggarwal</surname><given-names>A.</given-names></name>
<name><surname>Odorizzi</surname><given-names>P.M.</given-names></name>
<name><surname>Brodbeck</surname><given-names>J.</given-names></name>
<name><surname>van Buuren</surname><given-names>N.</given-names></name>
<name><surname>Moon</surname><given-names>C.</given-names></name>
<name><surname>Chang</surname><given-names>S.</given-names></name>
<name><surname>Adona</surname><given-names>M.</given-names></name>
<name><surname>Suthram</surname><given-names>S.</given-names></name>
<name><surname>Suri</surname><given-names>V.</given-names></name>
<name><surname>Trowe</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells</article-title><source>JHEP Rep.</source><year>2023</year><volume>5</volume><fpage>100664</fpage><pub-id pub-id-type="doi">10.1016/j.jhepr.2022.100664</pub-id><pub-id pub-id-type="pmid">36908748</pub-id>
</element-citation></ref><ref id="B43-viruses-16-01828"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Raimondo</surname><given-names>G.</given-names></name>
<name><surname>Locarnini</surname><given-names>S.</given-names></name>
<name><surname>Pollicino</surname><given-names>T.</given-names></name>
<name><surname>Levrero</surname><given-names>M.</given-names></name>
<name><surname>Zoulim</surname><given-names>F.</given-names></name>
<name><surname>Lok</surname><given-names>A.S.</given-names></name>
<collab>Taormina Workshop on Occult HBV Infection Faculty Members</collab>
</person-group><article-title>Update of the statements on biology and clinical impact of occult hepatitis B virus infection</article-title><source>J. Hepatol.</source><year>2019</year><volume>71</volume><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2019.03.034</pub-id><pub-id pub-id-type="pmid">31004683</pub-id>
</element-citation></ref><ref id="B44-viruses-16-01828"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saitta</surname><given-names>C.</given-names></name>
<name><surname>Pollicino</surname><given-names>T.</given-names></name>
<name><surname>Raimondo</surname><given-names>G.</given-names></name>
</person-group><article-title>Occult Hepatitis B Virus Infection: An Update</article-title><source>Viruses</source><year>2022</year><volume>14</volume><elocation-id>1504</elocation-id><pub-id pub-id-type="doi">10.3390/v14071504</pub-id><pub-id pub-id-type="pmid">35891484</pub-id>
</element-citation></ref><ref id="B45-viruses-16-01828"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>S.C.</given-names></name>
<name><surname>Wallin</surname><given-names>J.J.</given-names></name>
<name><surname>Ghosheh</surname><given-names>Y.</given-names></name>
<name><surname>Zahoor</surname><given-names>M.A.</given-names></name>
<name><surname>Sanchez Vasquez</surname><given-names>J.D.</given-names></name>
<name><surname>Nkongolo</surname><given-names>S.</given-names></name>
<name><surname>Fung</surname><given-names>S.</given-names></name>
<name><surname>Mendez</surname><given-names>P.</given-names></name>
<name><surname>Feld</surname><given-names>J.J.</given-names></name>
<name><surname>Janssen</surname><given-names>H.L.A.</given-names></name>
<etal/>
</person-group><article-title>Efficacy of antiviral therapy and host-virus interactions visualised using serial liver sampling with fine-needle aspirates</article-title><source>JHEP Rep.</source><year>2023</year><volume>5</volume><fpage>100817</fpage><pub-id pub-id-type="doi">10.1016/j.jhepr.2023.100817</pub-id><pub-id pub-id-type="pmid">37600958</pub-id>
</element-citation></ref><ref id="B46-viruses-16-01828"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lai</surname><given-names>C.L.</given-names></name>
<name><surname>Wong</surname><given-names>D.K.</given-names></name>
<name><surname>Wong</surname><given-names>G.T.</given-names></name>
<name><surname>Seto</surname><given-names>W.K.</given-names></name>
<name><surname>Fung</surname><given-names>J.</given-names></name>
<name><surname>Yuen</surname><given-names>M.F.</given-names></name>
</person-group><article-title>Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed</article-title><source>JHEP Rep.</source><year>2020</year><volume>2</volume><fpage>100112</fpage><pub-id pub-id-type="doi">10.1016/j.jhepr.2020.100112</pub-id><pub-id pub-id-type="pmid">32462119</pub-id>
</element-citation></ref><ref id="B47-viruses-16-01828"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yuen</surname><given-names>M.F.</given-names></name>
<name><surname>Lim</surname><given-names>S.G.</given-names></name>
<name><surname>Plesniak</surname><given-names>R.</given-names></name>
<name><surname>Tsuji</surname><given-names>K.</given-names></name>
<name><surname>Janssen</surname><given-names>H.L.A.</given-names></name>
<name><surname>Pojoga</surname><given-names>C.</given-names></name>
<name><surname>Gadano</surname><given-names>A.</given-names></name>
<name><surname>Popescu</surname><given-names>C.P.</given-names></name>
<name><surname>Stepanova</surname><given-names>T.</given-names></name>
<name><surname>Asselah</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection</article-title><source>N. Engl. J. Med.</source><year>2022</year><volume>387</volume><fpage>1957</fpage><lpage>1968</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2210027</pub-id><pub-id pub-id-type="pmid">36346079</pub-id>
</element-citation></ref><ref id="B48-viruses-16-01828"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gane</surname><given-names>E.</given-names></name>
<name><surname>Lim</surname><given-names>Y.S.</given-names></name>
<name><surname>Kim</surname><given-names>J.B.</given-names></name>
<name><surname>Jadhav</surname><given-names>V.</given-names></name>
<name><surname>Shen</surname><given-names>L.</given-names></name>
<name><surname>Bakardjiev</surname><given-names>A.I.</given-names></name>
<name><surname>Huang</surname><given-names>S.A.</given-names></name>
<name><surname>Cathcart</surname><given-names>A.L.</given-names></name>
<name><surname>Lempp</surname><given-names>F.A.</given-names></name>
<name><surname>Janas</surname><given-names>M.M.</given-names></name>
<etal/>
</person-group><article-title>Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials</article-title><source>J. Hepatol.</source><year>2023</year><volume>79</volume><fpage>924</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2023.05.023</pub-id><pub-id pub-id-type="pmid">37290591</pub-id>
</element-citation></ref><ref id="B49-viruses-16-01828"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Janssen</surname><given-names>H.L.A.</given-names></name>
<name><surname>Hou</surname><given-names>J.</given-names></name>
<name><surname>Asselah</surname><given-names>T.</given-names></name>
<name><surname>Chan</surname><given-names>H.L.Y.</given-names></name>
<name><surname>Zoulim</surname><given-names>F.</given-names></name>
<name><surname>Tanaka</surname><given-names>Y.</given-names></name>
<name><surname>Janczewska</surname><given-names>E.</given-names></name>
<name><surname>Nahass</surname><given-names>R.G.</given-names></name>
<name><surname>Bourgeois</surname><given-names>S.</given-names></name>
<name><surname>Buti</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection</article-title><source>Gut</source><year>2023</year><volume>72</volume><fpage>1385</fpage><lpage>1398</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2022-328041</pub-id><pub-id pub-id-type="pmid">36697207</pub-id>
</element-citation></ref><ref id="B50-viruses-16-01828"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allweiss</surname><given-names>L.</given-names></name>
<name><surname>Giersch</surname><given-names>K.</given-names></name>
<name><surname>Pirosu</surname><given-names>A.</given-names></name>
<name><surname>Volz</surname><given-names>T.</given-names></name>
<name><surname>Muench</surname><given-names>R.C.</given-names></name>
<name><surname>Beran</surname><given-names>R.K.</given-names></name>
<name><surname>Urban</surname><given-names>S.</given-names></name>
<name><surname>Javanbakht</surname><given-names>H.</given-names></name>
<name><surname>Fletcher</surname><given-names>S.P.</given-names></name>
<name><surname>L&#x000fc;tgehetmann</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Therapeutic shutdown of HBV transcripts promotes reappearance of the SMC5/6 complex and silencing of the viral genome in vivo</article-title><source>Gut</source><year>2022</year><volume>71</volume><fpage>372</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2020-322571</pub-id><pub-id pub-id-type="pmid">33509930</pub-id>
</element-citation></ref><ref id="B51-viruses-16-01828"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marcellin</surname><given-names>P.</given-names></name>
<name><surname>Gane</surname><given-names>E.J.</given-names></name>
<name><surname>Flisiak</surname><given-names>R.</given-names></name>
<name><surname>Manns</surname><given-names>M.P.</given-names></name>
<name><surname>Kaita</surname><given-names>K.D.</given-names></name>
<name><surname>Gaggar</surname><given-names>A.</given-names></name>
<name><surname>Lin</surname><given-names>L.</given-names></name>
<name><surname>Kitrinos</surname><given-names>K.M.</given-names></name>
<name><surname>Flaherty</surname><given-names>J.F.</given-names></name>
<name><surname>Subramanian</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Evidence for Ongoing Low-level Viremia in Patients with Chronic Hepatitis B Receiving Long-term Nucleos(t)ide Analog Therapy: 1861</article-title><source>Hepatology</source><year>2014</year><volume>60</volume><fpage>1093A</fpage></element-citation></ref><ref id="B52-viruses-16-01828"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Burdette</surname><given-names>D.L.</given-names></name>
<name><surname>Lazerwith</surname><given-names>S.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
<name><surname>Chan</surname><given-names>H.L.Y.</given-names></name>
<name><surname>Delaney Iv</surname><given-names>W.E.</given-names></name>
<name><surname>Fletcher</surname><given-names>S.P.</given-names></name>
<name><surname>Cihlar</surname><given-names>T.</given-names></name>
<name><surname>Feierbach</surname><given-names>B.</given-names></name>
</person-group><article-title>Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy</article-title><source>PLoS ONE</source><year>2022</year><volume>17</volume><elocation-id>e0262516</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0262516</pub-id><pub-id pub-id-type="pmid">35363817</pub-id>
</element-citation></ref><ref id="B53-viruses-16-01828"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yu</surname><given-names>X.</given-names></name>
<name><surname>Gong</surname><given-names>Q.</given-names></name>
<name><surname>Yu</surname><given-names>D.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Jing</surname><given-names>Y.</given-names></name>
<name><surname>Zoulim</surname><given-names>F.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
</person-group><article-title>Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss</article-title><source>Gut</source><year>2024</year><volume>73</volume><fpage>797</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2023-330577</pub-id><pub-id pub-id-type="pmid">37968095</pub-id>
</element-citation></ref><ref id="B54-viruses-16-01828"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cong</surname><given-names>Y.</given-names></name>
<name><surname>Endo</surname><given-names>T.</given-names></name>
</person-group><article-title>Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19</article-title><source>OMICS</source><year>2022</year><volume>26</volume><fpage>361</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1089/omi.2022.0068</pub-id><pub-id pub-id-type="pmid">35759424</pub-id>
</element-citation></ref><ref id="B55-viruses-16-01828"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Picard</surname><given-names>M.</given-names></name>
<name><surname>Scott-Boyer</surname><given-names>M.P.</given-names></name>
<name><surname>Bodein</surname><given-names>A.</given-names></name>
<name><surname>P&#x000e9;rin</surname><given-names>O.</given-names></name>
<name><surname>Droit</surname><given-names>A.</given-names></name>
</person-group><article-title>Integration strategies of multi-omics data for machine learning analysis</article-title><source>Comput. Struct. Biotechnol. J.</source><year>2021</year><volume>19</volume><fpage>3735</fpage><lpage>3746</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2021.06.030</pub-id><pub-id pub-id-type="pmid">34285775</pub-id>
</element-citation></ref><ref id="B56-viruses-16-01828"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reel</surname><given-names>P.S.</given-names></name>
<name><surname>Reel</surname><given-names>S.</given-names></name>
<name><surname>Pearson</surname><given-names>E.</given-names></name>
<name><surname>Trucco</surname><given-names>E.</given-names></name>
<name><surname>Jefferson</surname><given-names>E.</given-names></name>
</person-group><article-title>Using machine learning approaches for multi-omics data analysis: A review</article-title><source>Biotechnol. Adv.</source><year>2021</year><volume>49</volume><elocation-id>107739</elocation-id><pub-id pub-id-type="doi">10.1016/j.biotechadv.2021.107739</pub-id><pub-id pub-id-type="pmid">33794304</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="viruses-16-01828-f001"><label>Figure 1</label><caption><p>Schematics of hepatitis B virus viral transcription in single hepatocytes. (<bold>a</bold>) Heterogeneity of hepatocyte population in chronic HBV infection. Schematic of plates of hepatocytes, sinusoids, and bile canaliculi. Representative hepatocytes infected or not infected by HBV are shown. In hepatocytes containing productive cccDNA (red dots), viral RNAs coding for pgRNA, preCore, preS1, preS2/S, and various lengths of HBV X-related genes are generated, and the viral surface antigen and core protein are expressed. In cells harboring non-productive cccDNA (dark blue dots), only HBV X-related transcripts are produced. The non-productive or transcriptional inactive cccDNA appears not randomly distributed in host nucleus, with an apparent proximity preference to PML (promyelocytic leukeamia) bodies and/or heterochromatin regions like that from chromosome 19. In cells with no cccDNA but with integrated HBV DNA fragment(s) (cyan dots), depending on the integrated viral fragment and the integration site in the host genome, HBsAg and HBx, to a lesser extent, preS1-related transcripts are produced, and the viral proteins are expressed. Hepatocytes with HBV integration may undergo clone expansion. (<bold>b</bold>) Maintenance and reactivation of cccDNA transcription. Hepatocytes with productive viral transcription serve as the source of persistent infection in the liver. Hepatocytes are known to undergo continuous turnover usually within a time frame of 0.7 years for the diploid cells [<xref rid="B24-viruses-16-01828" ref-type="bibr">24</xref>]. Over the course, the hepatocyte population with productive viral transcription from cccDNA is likely replenished by either de novo infection of na&#x000ef;ve cells or reactivation of the transcription-inactive cccDNA within infected cells. Non-productive cccDNA can be activated through either super-infection or the expression of HBx from integrated HBV within infected cells.</p></caption><graphic xlink:href="viruses-16-01828-g001" position="float"/></fig></floats-group></article>